Medicine guide

Zoledronic acid medac

·

  • Prescription status not stated
  • Muscles, joints and bones
Active substance
Zoledronic acid
Made by
medac Gesellschaft für klinische Spezialpräparate mbH

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone. Treatment of adult patients with tumour-induced hypercalcaemia (TIH).

From the official label · 2026-09-30 · European Medicines Agency

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

United StatesNo exact match for this strength and form

BulgariaNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made bymedac Gesellschaft für klinische Spezialpräparate mbH
Active substanceZoledronic acid
Used inMuscles, joints and bones
ClassificationM05BA08 · Muscles, joints and bones
GenericYes — a generic medicine, according to the register
Authorised on2012-08-03
Last updated by the regulator2026-05-19
EMA product numberEMEA/H/C/002359

Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician

Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.